The Food and Drug Administration has approved a new form of pain-reliever OxyContin designed to reduce tampering and abuse.
It is difficult to cut, crush, chew, or dissolve the new pills, preserving the slow release of the active ingredient, oxycodone, over time. If a potential abuser tries to dissolve the pills in water, they form a gummy mass that cannot be injected.
After the new formulation is on the market, the FDA will require Purdue Pharma, the manufacturer of OxyContin, conduct a study of how well it meets the goal of reducing abuse and misuse. Purdue also must develop a Risk Evaluation and Mitigation Strategy (REMS) that includes a medication guide for patients and education for health care providers on the appropriate use of opiates to manage pain. Read the rest of this entry »